Rodgers Brothers’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-57,680
Closed -$718K 181
2016
Q4
$718K Sell
57,680
-800
-1% -$9.63K 0.28% 80
2016
Q3
$801K Sell
58,480
-500
-0.8% -$5.02K 0.32% 73
2016
Q2
$436K Hold
58,980
0.18% 106
2016
Q1
$377K Sell
58,980
-500
-0.8% -$2.8K 0.16% 107
2015
Q4
$372K Hold
59,480
0.17% 102
2015
Q3
$347K Sell
59,480
-500
-0.8% -$3.85K 0.17% 103
2015
Q2
$496K Buy
59,980
+2,200
+4% +$19.5K 0.23% 89
2015
Q1
$476K Sell
57,780
-2,500
-4% -$18.5K 0.23% 93
2014
Q4
$414K Sell
60,280
-5,500
-8% -$34.4K 0.21% 96
2014
Q3
$355K Sell
65,780
-800
-1% -$4.67K 0.19% 106
2014
Q2
$424K Hold
66,580
0.21% 101
2014
Q1
$537K Hold
66,580
0.26% 84
2013
Q4
$454K Buy
66,580
+15,150
+29% +$81.8K 0.23% 88
2013
Q3
$946K Buy
51,430
+1,600
+3% +$31.1K 0.52% 54
2013
Q2
$872K Buy
+49,830
New +$883K 0.52% 53

Other funds holding ARIA

Rodgers Brothers's ARIA Position: Q1 2017 in Review

Rodgers Brothers sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 57,680 shares — an estimated $718K sold.

Rodgers Brothers first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $946K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Rodgers Brothers reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Rodgers Brothers sold 57,680 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $718K.
  • Rodgers Brothers first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Rodgers Brothers's Ariad Pharmaceuticals Inc position peaked at $946K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Rodgers Brothers's 13F filing for Q1 2017, filed 15 May 2017.